Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000912057-00-016070
Filing Date
2000-04-04
Accepted
2000-04-04 00:00:00
Documents
1
Period of Report
2000-05-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A DEF 14A 88988
  Complete submission text file 0000912057-00-016070.txt   90455
Mailing Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Filer) CIK: 0001022622 (see all company filings)

EIN.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21589 | Film No.: 593249
SIC: 2834 Pharmaceutical Preparations